Simon Lovestone

Simon Lovestone

Janssen R&D
Beerse, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 236 publications

Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease.

Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 23, 2025

The evolution of Alzheimer's target identification: Towards a fusion of artificial and cellular intelligence.

The evolution of Alzheimer's target identification: Towards a fusion of artificial and cellular intelligence.

Journal: The journal of prevention of Alzheimer's disease

Published: September 05, 2025

The GNPC provides a proteomic resource for biomarker discovery and mechanistic insight in neurodegenerative disease.

The GNPC provides a proteomic resource for biomarker discovery and mechanistic insight in neurodegenerative disease.

Journal: Nature aging

Published: July 15, 2025

Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays.

Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 02, 2025

Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease.

Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 02, 2025

The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.

The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.

Journal: Nature medicine

Published: April 24, 2025

The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts.

The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 10, 2025

Synaptic protein CSF levels relate to memory scores in individuals without dementia.

Synaptic protein CSF levels relate to memory scores in individuals without dementia.

Journal: Research square

Published: August 07, 2024

Synaptic protein CSF levels relate to memory scores in individuals without dementia.

Synaptic protein CSF levels relate to memory scores in individuals without dementia.

Journal: Alzheimer's research & therapy

Published: June 19, 2024

Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiology.

Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiology.

Journal: Brain communications

Published: May 30, 2024

Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies.

Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies.

Journal: Fluids and barriers of the CNS

Published: April 15, 2024

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease.

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 03, 2024

Showing 1-12 of 236

Last Updated: 09/26/2026